| Date | Title | Description | |
|---|---|---|---|
| 23 Feb 2022 | On business and financial situation | The Company releases the press release related to the full year 2021 financial results | Download |
| 23 Feb 2022 | On business and financial situation | The Company releases the full year 2021 financial results presentation | Download |
| 23 Feb 2022 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
| 22 Feb 2022 | On buy-back programmes | ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022. | Download |
| 16 Feb 2022 | On business and financial situation | Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 26 Feb 2020 | Information on P&L | ROVI releases the press release related to the full year 2019 financial results | Download |
| 26 Feb 2020 | Information on P&L | ROVI releases the full year 2019 results presentation | Download |
| 26 Feb 2020 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 21 Dec 2011 | Acuerdos estratégicos con terceros (2) | Download | |
| 21 Dec 2011 | Acuerdos estratégicos con terceros | Download | |
| 08 Nov 2011 | Información sobre resultados (2) | Download | |
| 08 Nov 2011 | Información sobre resultados | Download | |
| 08 Nov 2011 | Composición de otros órganos de gestión y control | Download |